Site logo
Site logo
Site logo
  • Learn
    • COVID-19
    • Congressional Biomedical Research Caucus Briefings
      • Caucus Briefing Calendar
      • About the CBRC
      • Caucus Members
    • Facilities and Administrative Costs
    • News & Updates
    • Events
    • Research Funding Facts
    • Congressional Testimony
    • Beyond 2020: A Vision and Pathway for NIH Report
  • Advocate
    • Register to Vote
    • Take Action
    • Advocacy Tips
      • An Introduction to Science Public Policy
      • Ideas for Advocacy
      • Presentation Best Practices
      • Communicating with Congress
        • NIH and NSF Talking Points
      • Communicating with the Media
        • Writing a Letter to the Editor
      • Finding Community Allies
    • Join the CLS Grassroots Network
    • Rally for Medical Research
    • Letters to Congress
  • About CLS
    • Board of Directors
    • CLS History
    • Member Organizations
  • Contact Us
  • Donate

Congressional Testimony

Testimony National Science Foundation Part II:  Future Opportunities and Challenges for Science
March 21, 2017

National Science Foundation Part II: Future Opportunities and Challenges for Science

Statement of Keith R. Yamamoto, PhD Vice Chancellor, Science Policy and Strategy Director, UCSF Precision Medicine Professor, Cellular and Molecular Pharmacology University of California, San Francisco Before the Subcommittee on

Testimony The Important and Lifesaving Research Being Done with Fetal Cells and Fetal Tissue
March 2, 2016

The Important and Lifesaving Research Being Done with Fetal Cells and Fetal Tissue

Statement of Lawrence Goldstein, Ph.D. Distinguished Professor, Dept. of Cellular and Molecular Medicine, Dept. of Neurosciences Director, UC San Diego Stem Cell Program Scientific Director, Sanford Consortium for Regenerative Medicine

Testimony Unlocking the Cures for America’s Most Deadly Diseases
July 14, 2015

Unlocking the Cures for America’s Most Deadly Diseases

"Unlocking the Cures for America’s Most Deadly Diseases”

Testimony Driving Innovation Through Federal Investments
April 22, 2014

Driving Innovation Through Federal Investments

Dr. Keith Yamamoto, Vice Chancellor for Research, UCSF Executive Vice Dean, School of Medicine Professor, Cellular & Molecular Pharmacology Representing the Coalition for the Life Sciences April 22, 2014 Testimony

Testimony Appropriations for The National Institutes of Health
April 14, 2005

Appropriations for The National Institutes of Health

Dr. Karen A. Holbrook President, The Ohio State University Columbus, Ohio Representing The Joint Steering Committee for Public Policy April 14, 2005 Before the House Appropriations Subcommittee On Labor, Health

Testimony Appropriations for The National Science Foundation
March 25, 2004

Appropriations for The National Science Foundation

Representing The Joint Steering Committee for Public Policy Before the House Appropriations Subcommittee On VA, HUD and Independent Agencies United States House of Representatives Concerning FY 2005 Appropriations for The

Image module

6120 Executive Blvd.,
Suite 750
Rockville, MD 20852
T 301 347.9309
F 301 347.9310

CLS Member Organizations

Image module
Image module
Image module
Image module
Image module
Image module
Image module
Image module
Image module
div#stuning-header .dfd-stuning-header-bg-container {background-color: #0067ac;background-size: cover;background-position: center center;background-attachment: scroll;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 260px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}